No earnings forecast score is currently available for Bone Biologics Corp. The Biotechnology & Medical Research industry's average is 8.14. The average price target is 22.25, with a high of 22.25 and a low of 22.25.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Bone Biologics Corp's price target?
Analysts forecast that Bone Biologics Corp's price target is USD 22.25, with the highest forecast at USD 22.25 and the lowest forecast at USD 22.25.
How have Bone Biologics CorpBBLG's recent earnings per share performed?
The market expectation was USD -0.43, while Bone Biologics CorpBBLG's earnings per share (EPS) for the previous quarter was USD -0.38. EPS for the next quarter is expected at USD -0.39.